Skip to main content
. 2018 Sep 28;11:1756284818800307. doi: 10.1177/1756284818800307

Figure 1.

Figure 1.

Time to a first complication of cirrhosis experienced during the trial by treatment group and baseline disease severity.

(a) All complications of cirrhosis in patients with MELD score ⩾ 12 and INR ⩾1.2; (b) non-HE complications of cirrhosis in patients with MELD score ⩾ 12 and INR ⩾ 1.2; and (c) all complications of cirrhosis in patients with MELD score <12 and INR <1.2.

BID, twice daily; CI, confidence interval; HE, hepatic encephalopathy; HR, hazard ratio; INR, international normalized ratio; MELD, Model for End-Stage Liver Disease.